{
    "organizations": [],
    "uuid": "82dc28da8d6efb9b1547e479b1f773d8823569d7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vertex-pharma-says-established-who/brief-vertex-pharma-says-established-wholesale-acquisition-cost-of-292000-for-symdeko-in-u-s-on-annual-basis-idUSFWN1Q21HH",
    "ord_in_thread": 0,
    "title": "BRIEF-Vertex Pharma Says Established Wholesale Acquisition Cost Of $292,000 For SYMDEKO In U.S. On Annual Basis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Vertex Pharmaceuticals Inc:\n* VERTEX PHARMA - HAVE ESTABLISHED WHOLESALE ACQUISITION COST FOR SYMDEKO IN UNITED STATES OF $292,000 ON ANNUAL BASIS ($22,400 PER 28-DAY PACK)\n* VERTEX PHARMA SAYS ANTICIPATE FY 2018 TOTAL CF NET PRODUCT REVENUE OF $2.65 BILLION TO $2.80 BILLION FROM KALYDECO, ORKAMBI AND SYMDEKO - SEC FILING\n* VERTEX PHARMACEUTICALS -REITERATING ‍COMBINED GAAP RESEARCH AND DEVELOPMENT, SALES, GENERAL, ADMINISTRATIVE EXPENSES IN 2018 TO BE IN RANGE OF $1.80 TO $1.95 BILLION\n* VERTEX PHARMA- ‍ REITERATING COMBINED NON-GAAP RESEARCH AND DEVELOPMENT AND SALES, GENERAL, AND ADMINISTRATIVE EXPENSES WILL BE IN RANGE OF $1.50 BILLION TO $1.55 BILLION IN 2018​ Source text: ( bit.ly/2BTkdmr ) Further company coverage:\n ",
    "published": "2018-02-13T00:11:00.000+02:00",
    "crawled": "2018-02-13T00:22:41.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "vertex",
        "pharmaceutical",
        "inc",
        "vertex",
        "pharma",
        "established",
        "wholesale",
        "acquisition",
        "cost",
        "symdeko",
        "united",
        "state",
        "annual",
        "basis",
        "per",
        "pack",
        "vertex",
        "pharma",
        "say",
        "anticipate",
        "fy",
        "total",
        "cf",
        "net",
        "product",
        "revenue",
        "billion",
        "billion",
        "kalydeco",
        "orkambi",
        "symdeko",
        "sec",
        "filing",
        "vertex",
        "pharmaceutical",
        "gaap",
        "research",
        "development",
        "sale",
        "general",
        "administrative",
        "expense",
        "range",
        "billion",
        "vertex",
        "reiterating",
        "combined",
        "research",
        "development",
        "sale",
        "general",
        "administrative",
        "expense",
        "range",
        "billion",
        "billion",
        "source",
        "text",
        "company",
        "coverage"
    ]
}